An Algerian medical device manufacturer scaling production of dynamic blood glucose test strips needed a micro-dispense solution that balances ultra-fine reagent control with strict cost targets. Manual and slow jetting systems caused inconsistent reagent volumes, high material waste, and reduced enzyme/activity retention due to aggressive thermal or mechanical handling. The customer required a compact, easy-to-integrate valve that could deliver sub-nanoliter accuracy, stabilize line throughput, and preserve reagent bioactivity across long production runs.
Key failure modes were: (1) valve frequency limits and heavy controllers that reduced shot reliability at required takt speeds, (2) inconsistent drop formation leading to non-uniform reagent layers and variable strip sensitivity, (3) overly aggressive dispensing or heating that degraded enzyme activity, and (4) high material waste and downtime from nozzle clogging and maintenance—each raising per-unit cost and threatening regulatory consistency.
Mingseal supplied the KPS2000, a high-repetition-rate piezo jet valve and lightweight controller, to address these constraints on the Algerian line. Core technical fits:
Robust fluid path and nozzle options: Designed to reduce clogging and support gentle shear conditions that protect enzyme structure.
For Algerian manufacturers of dynamic blood glucose strips, KPS2000 provides a compact, high-speed jetting solution that reconciles micro-dose accuracy, cost control, reagent protection and production-line compatibility. Recommended deployment steps: qualify reagent rheology and nozzle geometry in FAT, lock dispense recipes into MES for traceability, and use inline metrology to close the control loop. Mingseal can support on-site tuning and pilot runs to validate performance against clinical sensitivity targets.